Donal Skelly
@skellydonal
Clinical Lecturer - Oxford University, Neurology SpR, Neuroimmunology, Delirium, Dementia, Immunology, SARS-CoV-2
ID: 448183513
27-12-2011 18:22:49
89 Tweet
222 Takipçi
1,1K Takip Edilen
This Saturday-entire year of med students gave blood for COVID serology and T cell analysis @OUH_research. Brilliantly organised by Donal Skelly and @LizzieStaffor15 denise o'donnell💙 and others. Three huge labs collaborating Tao Dong Oxford Vaccine Group Susanna Dunachie. Went like a machine
I am excited to post this advert for a new post-doctoral post in our lab, working on neuroinflammation, #delirium and brain energy metabolism, in collaboration with John Newman John Newman, MD, PhD . I would really appreciate some RETWEETs to help it find its audience !
NEW: a common response to reports of hospitals struggling this winter is "it’s no different to a bad flu season!" I’ve tracked down historical data on flu ICU admissions, including winter 2017-18, a record high. Here’s how England’s Covid winter compares to a bad flu season 📹
Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. | Research Square. First author Dr Donal Skelly from Waterford leading on this important research on vaccine efficacy researchsquare.com/article/rs-226…
Great to see our PITCH pre-print researchsquare.com/article/rs-226… of work supported by Department of Health and Social Care and UK-CIC referenced by Nature @WilliamSiwJames Ellie Barnes 🚵♀️ Susanna Dunachie Donal Skelly nature.com/articles/d4158…
V happy to get our pitchstudy led by @Thushan_deSilva out today. Thanks++ to all NIHR Oxford Biomedical Research Centre OUH Nuffield Department of Medicine who worked hard on this especially Ellie Barnes 🚵♀️ Donal Skelly Sile Johnson @pippa_matt Patpong (Palm) Rongkard, PhD Dr Kochi Khamosh Ane Ogbe John Frater Azim Ansari Anthony Brown
ICYMI 📰 Antibody levels and ‘helper’ T cells are boosted after a ~10 week interval between 2 doses of the Pfizer #COVID19 vaccine This @PITCHstudy research involved 5 UK centres 🤝 University of Oxford University of Liverpool The University of Sheffield Newcastle University Uni of Birmingham 👉 uk-cic.org/news/longer-in…
Honoured to be a part of this with Donal Skelly writing about systemic inflammation, #delirium and #dementia
Our pitchstudy paper on the impact of Pfizer dosing interval (which we preprinted in July) is now live Cell. Many thanks to all our many collaborators & the HCWs who participated Lance Turtle @Thushan_deSilva Carroll Lab Professor Alex Richter Christopher J A Duncan Chris Dold
Our pitchstudy comparing standard and extended dosing intervals of Pfizer Inc. BNT162b2 mRNA vaccine is out now Cell. Great collaboration with Professor Alex Richter Susanna Dunachie Christopher J A Duncan Lance Turtle @Thushan_deSilva Carroll Lab and Screaton lab. cell.com/cell/fulltext/…
1/ Proud to be part of this pitchstudy ‘Immunogenicity of standard and extended dosing intervals of Pfizer Inc. BNT162b2 mRNA vaccine’ which is out in Cell cell.com/cell/fulltext/… Thread below 👇
Thrilled to see our work on the durability of immune memory responses to #COVID19 finally published in Nature Communications This work wouldn't be possible without incredible team Susanna Dunachie Ellie Barnes 🚵♀️ PaulKlenermanLab Ane Ogbe Daniel O'Connor Donal Skelly Chris Dold pitchstudy 🧵👇
We held a thank you event in Oxford today OUH NIHR Oxford Biomedical Research Centre for our OPTIC/PITCH/The VIBRANT Study UK healthcare worker participants. Fab to hear all our participants' Qs on what we have achieved, immunity of "Never Nevers" etc. Great organising from Sofia/Lizzie/Anni/Callum & all